Category: Pharma Industry

AbbVie Replies to Louisiana’s Request for Court to Expedite Decision on Contract Pharmacy Law

April 11, 2024 Rich Daly, Editor in Chief Views

Drug manufacturer AbbVie is challenging Louisiana's state 340B contract pharmacy access law in a federal district court.

Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca’s Lawsuit Against Arkansas’ 340B Contract Pharmacy Law Reassigned to Judge Who Previously Upheld It

April 9, 2024 William Newton, Associate Editor/Senior Writer Views

AstraZeneca's lawsuit challenging Arkansas' 340B contract pharmacy access law has been transferred to a federal judge who previously upheld it.

A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Manufacturer Refunds to 340B Providers Have Steadily Increased Since 2019, Says Analysis

April 9, 2024 Rich Daly, Editor in Chief Views

An analysis from the law firm Spencer Fane found that 340B refunds have been concentrated among certain manufacturers and drugs.

A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

April 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.

Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Stakeholders Clash on Patient Definition, 340B Spending Requirements in Comments on Senate ‘Group of Six’ Draft Overhaul

April 4, 2024 William Newton, Associate Editor/Senior Writer Views

Advocacy groups for providers and drugmakers had diverging views in their comments on a draft Senate 340B overhaul.

Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Officially Issues Contract Pharmacy Restrictions

April 4, 2024 Rich Daly, Editor in Chief Views

Pharmaceutical manufacturer Genentech has formally implemented 340B contract pharmacy restrictions for hospitals.

Drugmaker Genentech has formally issued contract pharmacy restrictions after it gave some 340B hospitals advance notice last month of its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie Adds Cancer Drug to Contract Pharmacy Restriction Policy

April 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Drug manufacturer AbbVie recently added a cancer medication to its 340B contract pharmacy restrictions for hospitals.

Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Contract Pharmacies Have Proliferated, Conservative Group Says, Citing Data from Pharma-Funded Think Tank

April 4, 2024 Rich Daly, Editor in Chief Views

A Paragon Health Institute analysis found the share of 340B contract pharmacies per covered entity has increased in recent years.

Active 340B contract pharmacies reached 17,250 in 2024, according to a conservative think tank using data collected by another group funded by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision

April 2, 2024 William Newton, Associate Editor/Senior Writer Views

At least nine drugmakers have modified their contract pharmacy restrictions in Arkansas after the state said it planned to enforce its 340B law following an appeals court decision. An additional nine manufacturers loosened restrictions prior to the court decision.

Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sumitomo Is Thirty-Second Company to Implement Contract Pharmacy Restrictions

April 2, 2024 Rich Daly, Editor in Chief Views

Sumitomo is the 32nd pharmaceutical manufacturer to place restrictions on 340B drug shipment in the contract pharmacy setting.

Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live